MedTrace Logo

Clinical Study of the inQB8 TTVR System (The MonarQ Study)

NCT06611579 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-05-18

No results posted yet for this study

Summary

Prospective, multi-center study to assess safety and performance of the inQB8 MonarQ Tricuspid Valve Replacement System.

Conditions

  • Tricuspid Valve Regurgitation

Interventions

DEVICE

Transcatheter Tricuspid Valve Replacement

Replacement of the tricuspid valve using a transcatheter approach

Sponsors & Collaborators

  • inQB8 Medical Technologies, LLC

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2027-10-31
Completion
2030-10-31
FDA Device
Yes

Countries

  • United States
  • Belgium
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06611579 on ClinicalTrials.gov